103 related articles for article (PubMed ID: 18664394)
1. The therapeutic effect of TV-5010 in a murine model of inflammatory bowel disease -- Dextran induced colitis.
Aharoni R; Brenner O; Cohen A; Arnon R
Int Immunopharmacol; 2008 Nov; 8(11):1578-88. PubMed ID: 18664394
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells.
Aharoni R; Sonego H; Brenner O; Eilam R; Arnon R
Immunol Lett; 2007 Oct; 112(2):110-9. PubMed ID: 17719654
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Aharoni R; Kayhan B; Brenner O; Domev H; Labunskay G; Arnon R
J Pharmacol Exp Ther; 2006 Jul; 318(1):68-78. PubMed ID: 16624971
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of glatiramer acetate treatment on syndecan-1 expression in dextran sodium sulfate colitis.
Yablecovitch D; Shabat-Simon M; Aharoni R; Eilam R; Brenner O; Arnon R
J Pharmacol Exp Ther; 2011 May; 337(2):391-9. PubMed ID: 21310817
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of the immunomodulator glatiramer acetate on trinitrobenzene sulfonic acid-induced experimental colitis.
Aharoni R; Kayhan B; Arnon R
Inflamm Bowel Dis; 2005 Feb; 11(2):106-15. PubMed ID: 15677903
[TBL] [Abstract][Full Text] [Related]
6. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Katada K; Takagi T; Tsuboi H; Isozaki Y; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
Int J Mol Med; 2006 Jun; 17(6):997-1004. PubMed ID: 16685407
[TBL] [Abstract][Full Text] [Related]
8. Role of interleukin-21 isoform in dextran sulfate sodium (DSS)-induced colitis.
Araki A; Nara H; Rahman M; Onoda T; Li J; Juliana FM; Jin L; Murata K; Takeda Y; Asao H
Cytokine; 2013 May; 62(2):262-71. PubMed ID: 23557800
[TBL] [Abstract][Full Text] [Related]
9. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
[TBL] [Abstract][Full Text] [Related]
10. Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8⁺ regulatory cells.
Yao Y; Han W; Liang J; Ji J; Wang J; Cantor H; Lu L
Eur J Immunol; 2013 Jan; 43(1):125-36. PubMed ID: 23002042
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
[TBL] [Abstract][Full Text] [Related]
13. alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Ishikawa T; Handa O; Matsumoto N; Yagi N; Matsuyama K; Yoshida N; Yoshikawa T; Kotake Y
Antioxid Redox Signal; 2002 Feb; 4(1):195-206. PubMed ID: 11970853
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic effects of Lonicera japonica extract on dextran sulphate sodium-induced colitis in a mouse model by the inhibition of the Th1/Th17 response.
Park JW; Bae H; Lee G; Hong BG; Yoo HH; Lim SJ; Lee K; Kim J; Ryu B; Lee BJ; Bae J; Lee H; Bu Y
Br J Nutr; 2013 Jan; 109(2):283-92. PubMed ID: 22569277
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium bovis Bacillus Calmette-Guérin killed by extended freeze-drying reduces colitis in mice.
Lagranderie M; Kluge C; Kiefer-Biasizzo H; Abolhassani M; Nahori MA; Fitting C; Huerre M; Bandeira A; Bercovier H; Marchal G
Gastroenterology; 2011 Aug; 141(2):642-52, 652.e1-4. PubMed ID: 21683076
[TBL] [Abstract][Full Text] [Related]
16. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
[TBL] [Abstract][Full Text] [Related]
17. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
18. Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis.
Simpson SJ; Holländer GA; Mizoguchi E; Allen D; Bhan AK; Wang B; Terhorst C
Eur J Immunol; 1997 Jan; 27(1):17-25. PubMed ID: 9021993
[TBL] [Abstract][Full Text] [Related]
19. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ.
Aharoni R; Kayhan B; Eilam R; Sela M; Arnon R
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14157-62. PubMed ID: 14614135
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications.
Arnon R; Aharoni R
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14593-8. PubMed ID: 15371592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
